GE Healthcare Technologies Inc (1GEHC) Stock Forecast & Price Target

Compare

0 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1GEHC Analyst Ratings

Moderate Buy

6 Buy

4 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Healthcare Technologies Inc

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1GEHC Stock 12 Month Forecast

Average Price Target

€76.26

▲(16.78% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for GE Healthcare Technologies Inc in the last 3 months. The average price target is €76.26 with a high forecast of €82.42 and a low forecast of €69.40. The average price target represents a 16.78% change from the last price of €65.30.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"59":"€59","65":"€65","71":"€71","77":"€77","83":"€83"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":82.4172728,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€82.42</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":76.257666096,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€76.26</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":69.4040192,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€69.40</span>\n  </div></div>","useHTML":true}}],"tickPositions":[59,65,71,77,83],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,63.91,65.33363636923076,66.75727273846154,68.1809091076923,69.60454547692308,71.02818184615384,72.45181821538462,73.87545458461538,75.29909095384616,76.72272732307692,78.1463636923077,79.57000006153847,80.99363643076924,{"y":82.4172728,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,63.91,64.85982046892308,65.80964093784615,66.75946140676923,67.7092818756923,68.65910234461538,69.60892281353846,70.55874328246153,71.50856375138461,72.45838422030769,73.40820468923076,74.35802515815384,75.30784562707692,{"y":76.257666096,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,63.91,64.33261686153845,64.75523372307691,65.17785058461538,65.60046744615384,66.0230843076923,66.44570116923076,66.86831803076923,67.29093489230769,67.71355175384615,68.1361686153846,68.55878547692308,68.98140233846154,{"y":69.4040192,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":62.842,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.842,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.842,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.842,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.842,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.842,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.842,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.842,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.154,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.851,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.462,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":62.801,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.91,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€82.42

Average Price Target€76.26

Lowest Price Target€69.40

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Matt Miksic

Barclays

€74.61

Hold

14.26%

Upside

Reiterated

10/31/25

Isla Carelynx

TR | OpenAI - 4o

€78.08→€72.87

Buy

11.60%

Upside

Reiterated

10/31/25

AI Generated ArticleAI Generated Article

Matthew Taylor

Jefferies

€82.42

Buy

26.21%

Upside

Reiterated

10/30/25

Jefferies Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC)

Larry Biegelsen

Wells Fargo

€77.21→€75.48

Buy

15.58%

Upside

Reiterated

10/30/25

GE Healthcare Technologies Inc (GEHC) Gets a Buy from Wells Fargo

Vijay Kumar

Evercore ISI

€76.34→€79.81

Buy

22.23%

Upside

Reiterated

10/30/25

Evercore ISI Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC)

Patrick Wood

Morgan Stanley

€64.2→€69.4

Hold

6.28%

Upside

Reiterated

10/30/25

Balanced Outlook on GE Healthcare Technologies Inc: Hold Recommendation Amid Market Uncertainties

Unknown Analyst

Mizuho Securities

Not Ranked

Mizuho Securities

€82.42

Buy

26.21%

Upside

Reiterated

10/30/25

Travis Steed

Bank of America Securities

€71.14

Hold

8.94%

Upside

Reiterated

10/29/25

GE Healthcare Technologies Inc.: Strong Q3 Performance Overshadowed by Conservative Guidance and Cautious Product Launch

Ryan Zimmerman

BTIG

€77.21→€75.48

Buy

15.58%

Upside

Reiterated

10/29/25

GE HealthCare price target lowered to $87 from $89 at BTIGGE HealthCare price target lowered to $87 from $89 at BTIG

Joanne Wuensch

Citi

€80.68→€72.01

Hold

10.27%

Upside

Downgraded

10/07/25

GE HealthCare downgraded to Neutral from Buy at CitiGE HealthCare downgraded to Neutral from Buy at Citi

Navann Ty

Exane BNP Paribas

€79.81

Buy

22.23%

Upside

Reiterated

09/10/25

GE Healthcare Technologies Inc (GEHC) Receives a Buy from Exane BNP Paribas

Rick Wise

Stifel Nicolaus

€78.08

Buy

19.57%

Upside

Reiterated

08/04/25

Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV), Axsome Therapeutics (NASDAQ: AXSM) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

Suraj Kalia

Oppenheimer

€77.21

Buy

18.24%

Upside

Reiterated

07/31/25

Oppenheimer Remains a Buy on GE Healthcare Technologies Inc (GEHC)

David Roman

Goldman Sachs

€71.14→€73.74

Buy

12.93%

Upside

Reiterated

06/10/25

Positive Outlook for GE Healthcare Technologies Amid Strong U.S. Hospital Expenditure and Global Stabilization

Graham Doyle

UBS

€63.33

Hold

-3.02%

Downside

Upgraded

05/05/25

GE HealthCare upgraded to Neutral from Sell at UBSGE HealthCare upgraded to Neutral from Sell at UBS

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Matt Miksic

Barclays

€74.61

Hold

14.26%

Upside

Reiterated

10/31/25

Isla Carelynx

TR | OpenAI - 4o

€78.08→€72.87

Buy

11.60%

Upside

Reiterated

10/31/25

AI Generated ArticleAI Generated Article

Matthew Taylor

Jefferies

€82.42

Buy

26.21%

Upside

Reiterated

10/30/25

Jefferies Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC)

Larry Biegelsen

Wells Fargo

€77.21→€75.48

Buy

15.58%

Upside

Reiterated

10/30/25

GE Healthcare Technologies Inc (GEHC) Gets a Buy from Wells Fargo

Vijay Kumar

Evercore ISI

€76.34→€79.81

Buy

22.23%

Upside

Reiterated

10/30/25

Evercore ISI Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC)

Patrick Wood

Morgan Stanley

€64.2→€69.4

Hold

6.28%

Upside

Reiterated

10/30/25

Balanced Outlook on GE Healthcare Technologies Inc: Hold Recommendation Amid Market Uncertainties

Unknown Analyst

Mizuho Securities

Not Ranked

Mizuho Securities

€82.42

Buy

26.21%

Upside

Reiterated

10/30/25

Travis Steed

Bank of America Securities

€71.14

Hold

8.94%

Upside

Reiterated

10/29/25

GE Healthcare Technologies Inc.: Strong Q3 Performance Overshadowed by Conservative Guidance and Cautious Product Launch

Ryan Zimmerman

BTIG

€77.21→€75.48

Buy

15.58%

Upside

Reiterated

10/29/25

GE HealthCare price target lowered to $87 from $89 at BTIGGE HealthCare price target lowered to $87 from $89 at BTIG

Joanne Wuensch

Citi

€80.68→€72.01

Hold

10.27%

Upside

Downgraded

10/07/25

GE HealthCare downgraded to Neutral from Buy at CitiGE HealthCare downgraded to Neutral from Buy at Citi

Navann Ty

Exane BNP Paribas

€79.81

Buy

22.23%

Upside

Reiterated

09/10/25

GE Healthcare Technologies Inc (GEHC) Receives a Buy from Exane BNP Paribas

Rick Wise

Stifel Nicolaus

€78.08

Buy

19.57%

Upside

Reiterated

08/04/25

Analysts Offer Insights on Healthcare Companies: AbbVie (NYSE: ABBV), Axsome Therapeutics (NASDAQ: AXSM) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

Suraj Kalia

Oppenheimer

€77.21

Buy

18.24%

Upside

Reiterated

07/31/25

Oppenheimer Remains a Buy on GE Healthcare Technologies Inc (GEHC)

David Roman

Goldman Sachs

€71.14→€73.74

Buy

12.93%

Upside

Reiterated

06/10/25

Positive Outlook for GE Healthcare Technologies Amid Strong U.S. Hospital Expenditure and Global Stabilization

Graham Doyle

UBS

€63.33

Hold

-3.02%

Downside

Upgraded

05/05/25

GE HealthCare upgraded to Neutral from Sell at UBSGE HealthCare upgraded to Neutral from Sell at UBS

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GE Healthcare Technologies Inc

1 Month

xxx

Success Rate

5/8 ratings generated profit

Average Return

+1.43%

reiterated a xxx

rating 20 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 62.50% of your transactions generating a profit, with an average return of +1.43% per trade.

3 Months

xxx

Success Rate

7/9 ratings generated profit

Average Return

-0.92%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of -0.92% per trade.

1 Year

Suraj KaliaOppenheimer

Success Rate

4/7 ratings generated profit

Average Return

-1.43%

reiterated a buy rating 3 months ago

Copying Suraj Kalia's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of -1.43% per trade.

2 Years

xxx

Success Rate

4/8 ratings generated profit

Average Return

-1.71%

reiterated a xxx

rating 20 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -1.71% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1GEHC Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1GEHC has received 21 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. 1GEHC average Analyst price target in the past 3 months is 76.26.

Each month's total comprises the sum of three months' worth of ratings.

1GEHC Financial Forecast

1GEHC Earnings Forecast

Next quarter’s earnings estimate for 1GEHC is €1.22 with a range of €1.04 to €1.26. The previous quarter’s EPS was €0.93. 1GEHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 1GEHC has Preformed in-line its overall industry.

1GEHC Sales Forecast

Next quarter’s sales forecast for 1GEHC is €4.88B with a range of €4.76B to €4.95B. The previous quarter’s sales results were €4.47B. 1GEHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 1GEHC has Preformed in-line its overall industry.

1GEHC Stock Forecast FAQ

What is IT:1GEHC’s average 12-month price target, according to analysts?

Based on analyst ratings, GE Healthcare Technologies Inc’s 12-month average price target is 76.26.

What is IT:1GEHC’s upside potential, based on the analysts’ average price target?

GE Healthcare Technologies Inc has 16.78% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GE Healthcare Technologies Inc a Buy, Sell or Hold?

GE Healthcare Technologies Inc has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 4 hold ratings and 0 sell ratings.

What is GE Healthcare Technologies Inc’s share price target?

The average share price target for GE Healthcare Technologies Inc is 76.26. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €82.42 ,and the lowest forecast is €69.40. The average share price target represents 16.78% Increase from the current price of €65.3.

What do analysts say about GE Healthcare Technologies Inc?

GE Healthcare Technologies Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of GE Healthcare Technologies Inc?

To buy shares of IT:1GEHC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

GE Healthcare Technologies Inc (1GEHC) Stock Forecast & Price Target

1GEHC Analyst Ratings

1GEHC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering GE Healthcare Technologies Inc

1GEHC Analyst Recommendation Trends

1GEHC Financial Forecast

1GEHC Earnings Forecast

1GEHC Sales Forecast

1GEHC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts